Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Participants who responded best to the supplement were often younger or had fewer metabolic complications
Aug 1 2021:1-9
It is not intended for human consumption, diagnostic use, or therapeutic application
Variables specifically relevant to venous thromboembolism risk, including anticoagulant/antiplatelet use (9.1% vs 8.8%), primary thrombophilia (0.7% vs 0.7%), varicose veins (3.4% vs 3.3%), hormone replacement therapy (3.6% vs 3.5%), and pregnancy (1.5% vs 1.4%), were also well balanced between cohorts
Cell viability assay Cell proliferation was detected via a CCK-8 assay (Biosharp, China) or a CellTiter-Glo assay (Promega) according to the manufacturers instructions
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
